Article thumbnail

Cell-Intrinsic NF-κB Activation Is Critical for the Development of Natural Regulatory T Cells in Mice

By Eva Gückel, Silke Frey, Mario M. Zaiss, Georg Schett, Sankar Ghosh and Reinhard E. Voll
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1996). A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells.
  2. (2006). A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.
  3. (2005). A function for interleukin 2 in Foxp3-expressing regulatory T cells.
  4. (2003). A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice.
  5. (2008). A two-step process for thymic regulatory T cell development.
  6. (1999). An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation.
  7. (2003). An essential role for Scurfin in CD4+CD25+ T regulatory cells.
  8. (2003). AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNFalpha in Jurkat leukemic cells.
  9. (2000). B7/ CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
  10. (2001). Bcl10 is a positive regulator of antigen receptor-induced activation of NFkappaB and neural tube closure.
  11. (2010). c-Rel but not NF-kappaB1 is important for T regulatory cell development.
  12. (2010). c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells.
  13. (2009). c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells.
  14. (2009). CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells.
  15. (2010). CARMA1 regulation of regulatory T cell development involves modulation of interleukin-2 receptor signaling.
  16. (2002). CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2.
  17. (1998). CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.
  18. (2006). CD4+CD25+Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice.
  19. (2007). Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice.
  20. (2003). Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function.
  21. (2009). Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery.
  22. (2003). Control of regulatory T cell development by the transcription factor Foxp3.
  23. (2003). Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
  24. (2009). Critical regulation of early Th17 cell differentiation by interleukin-1 signaling.
  25. (2003). Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells.
  26. (2001). Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells.
  27. (2000). Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.
  28. (2005). Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling.
  29. (2009). Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome.
  30. (2004). Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation.
  31. (2003). Differential requirement for Malt1 in T and B cell antigen receptor signaling.
  32. (2008). Differential requirement of PKC-theta in the development and function of natural regulatory T cells.
  33. (2003). Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells.
  34. (2005). Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period.
  35. (2003). Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance.
  36. (1991). Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education.
  37. (2005). Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells.
  38. (2003). Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
  39. (2007). Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature.
  40. (2005). Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization.
  41. (2007). I kappa B kinase 2/beta deficiency controls expansion of autoreactive T cells and suppresses experimental autoimmune encephalomyelitis.
  42. (2008). IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development.
  43. (2000). Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.
  44. (1995). Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.
  45. (2004). In vivo instruction of suppressor commitment in naive T cells.
  46. (2005). Inducing and expanding regulatory T cell populations by foreign antigen.
  47. (2007). Interleukin-2 receptor signaling in regulatory T cell development and homeostasis.
  48. (2006). Interleukin-2-dependent mechanisms of tolerance and immunity in vivo.
  49. Leung BP (2006) CD4+CD25+ regulatory T cells in health and disease.
  50. (2008). Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire.
  51. (2001). Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells.
  52. (2003). Mature T cells depend on signaling through the IKK complex.
  53. (2000). NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development.
  54. (2001). NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells.
  55. (2007). NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta.
  56. (2009). NFkappaB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants.
  57. (2007). Nonredundant roles for Stat5a/b in directly regulating Foxp3.
  58. (2009). Nuclear factorkappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor.
  59. (2002). Origin of regulatory T cells with known specificity for antigen.
  60. (1997). Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB.
  61. (2008). Pharmacological IKK2 inhibition blocks liver steatosis and initiation of nonalcoholic steatohepatitis.
  62. (2000). PKCtheta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes.
  63. (2009). Proteolysis of NF-kappaB1 p105 is essential for T cell antigen receptorinduced proliferation.
  64. (2009). Regulation and function of NF-kappaB transcription factors in the immune system.
  65. (2007). Regulatory T cell development in the absence of functional Foxp3.
  66. (1995). RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.
  67. (2003). Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation.
  68. (2008). Rethinking the molecular definition of regulatory T cells.
  69. (2010). Roles of the NF-kappaB pathway in lymphocyte development and function.
  70. (2005). Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen.
  71. (2008). Shared principles in NF-kappaB signaling.
  72. Singer A (2005) CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.
  73. (2001). The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.
  74. (2003). The MAGUK family protein CARD11 is essential for lymphocyte activation.
  75. (2009). The role of NFkappaB and Smad3 in TGF-beta-mediated Foxp3 expression.
  76. (1990). The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome.
  77. (2001). Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist selfpeptide.
  78. (1999). Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.
  79. (2005). Transplantation tolerance in NF-kappaB-impaired mice is not due to regulation but is prevented by transgenic expression of Bcl-xL.
  80. (2001). X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.